Zobrazeno 1 - 10
of 31
pro vyhledávání: '"деносумаб"'
Publikováno v:
Креативная хирургия и онкология, Vol 12, Iss 2, Pp 151-158 (2022)
The occurrence of drug-induced osteonecrosis of the jaw in cancer patients treated using bone-modifying medications (bisphosphonates and denosumab) is a highly relevant research problem studied by dentists, maxillofacial surgeons, and oncologists. De
Externí odkaz:
https://doaj.org/article/691f176160614106b2200f9083d51e4f
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 1, Pp 10-16 (2018)
Skeletal-related events - a significant medical and economic problem for women with metastases during the treatment of breast cancer. Clinico-economic evaluation was performed to compare the use of denosumab and zoledronic acid in this category of pa
Externí odkaz:
https://doaj.org/article/ba4469bd359546e6b26509201091f0ad
Autor:
Oleg Vyrva, Dmytro Mikhanovskiy, Marianna Bitsadze, Olga Golovina, Zinaida Danуshchuk, Oleksandr Babych
Publikováno v:
Ортопедия, травматология и протезирование; № 4 (2021); 33-41
ORTHOPAEDICS, TRAUMATOLOGY and PROSTHETICS; No. 4 (2021); 33-41
ORTHOPAEDICS, TRAUMATOLOGY and PROSTHETICS; No. 4 (2021); 33-41
Giant cell tumor of bone (GCTB) is a benign osteolytic tumor with an aggressive course, affects the metaphyseal and epiphyseal areas of bone. GCTB is RANKL-positive tumor. Therefore, RANKL is a promising target for directed influence on the processes
Autor:
Gerold Holzer, Lukas A. Holzer
Publikováno v:
PAIN. JOINTS. SPINE; Том 8, № 1 (2018); 1-6
Боль. Суставы. Позвоночник-Bolʹ, sustavy, pozvonočnik; Том 8, № 1 (2018); 1-6
Біль. Суглоби. Хребет-Bolʹ, sustavy, pozvonočnik; Том 8, № 1 (2018); 1-6
Боль. Суставы. Позвоночник-Bolʹ, sustavy, pozvonočnik; Том 8, № 1 (2018); 1-6
Біль. Суглоби. Хребет-Bolʹ, sustavy, pozvonočnik; Том 8, № 1 (2018); 1-6
Over the past few decades, the number of endoprosthetic joint replacements has steadily increased. Most of these patients are of higher age and due to osteoporosis may have a reduced bone quality. In te case of patients with joint replacements and os
Autor:
L V Egshatyan, L Ya Rozhinskaya
Publikováno v:
Остеопороз и остеопатии, Vol 17, Iss 2, Pp 29-35 (2014)
The article presents a literature review summarizing the contemporary data on the effects of drug therapy on various parameters of renal osteodystrophy: phosphate binders, vitamin D preparations, bisphosphonates, denosumab, and calcimimetics. We disc
Externí odkaz:
https://doaj.org/article/25baa913ab59463c96116c8342b7186c
Autor:
N G Mokrysheva, L Ya Rozhinskaya
Publikováno v:
Остеопороз и остеопатии, Vol 16, Iss 1, Pp 29-33 (2013)
Постепенное увеличение продолжительности жизни человека, стремление к улучшению ее качества требует улучшения результатов профилакти
Externí odkaz:
https://doaj.org/article/20e1eb4932d64e19bcae8f95ef5618b9
Autor:
Bogdan Maksimenko, Anatolii Diedkov
Publikováno v:
Ортопедия, травматология и протезирование; № 3 (2021); 59-64
ORTHOPAEDICS, TRAUMATOLOGY and PROSTHETICS; No. 3 (2021); 59-64
ORTHOPAEDICS, TRAUMATOLOGY and PROSTHETICS; No. 3 (2021); 59-64
Surgical intervention remains a gold standard for the treatment of giant cell tumors (GCT) of long bones. The significant risk of recurrence after the curettage and a high complication rate after radical resections is still an unsolved problem. Targe
Autor:
M R Lichinitser, N N Semenov
Publikováno v:
Современная онкология, Vol 11, Iss 4, Pp 5-7 (2009)
В течение десятилетий у больных ранним раком молочной железы (РМЖ) с положительными рецепторами половых гормонов использовался Тамокси
Externí odkaz:
https://doaj.org/article/92b9fb97837e481ba4f3bbc46fd735a1
Диффузносклерозирующий остеомиелит (ДСО) – редкое заболевание челюстей, трудно поддающееся лечению. В настоящее время предложено множ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5ed31196c7f1524242fd6aa30304310
Autor:
Irina A. Skripnikova, Zhanna E. Belaya, Alexey V. Petryaykin, Kseniya Y. Belova, Ekaterina N. Dudinskaya, Leonid Y. Farba, Svetlana S. Rodionova, Ivan Ivanovich Dedov, Olga V. Ershova, S V Yureneva, Timur Т. Tsoriev, N V Tarbaeva, N V Toroptsova, Olga М. Lesnyak, O V YaKUShEVSKAYa, Elizaveta O. Mamedova, Larisa Nikankina, Oksana М. Drapkina, Elena Valer'evna Biryukova, I V Kryukova, Galina А. Mel’nichenko, Nikolay V. Zagorodniy, Ekaterina Pigarova, Tatyana O. Chernova, Larisa А. Marchenkova, John A. Kanis, Olga N. Tkacheva, Aleksandr V. Dreval, Tatiana A. Grebennikova, O A NIKITINSKAYa, Larisa Dzeranova, L Y Rozhinskaya, Ol’ga B. Ilyukhina
[English] A summary of the draft federal clinical guidelines on osteoporosis developed by members of the Russian Association of Endocrinologists, the Russian Association for Osteoporosis, the Association of Rheumatologists of Russia, the Association
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caca4ce7021b97920ca706ab73c6b5df
https://acuresearchbank.acu.edu.au/item/8x98y/summary-of-the-draft-federal-clinical-guidelines-for-osteoporosis
https://acuresearchbank.acu.edu.au/item/8x98y/summary-of-the-draft-federal-clinical-guidelines-for-osteoporosis